Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03472469 · ClinicalTrials.gov registry record · Phase 4
MAST Trial: Multi-modal Analgesic Strategies in Trauma
A Phase 4 study, sponsored by The University of Texas Health Science Center, Houston.
- Completed
- Registry status
- Phase 4
- Development phase
- 1,561
- Enrollment target
NCT03472469 is a Phase 4 study that has completed, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 1,561 participants.
The verdict
NCT03472469, a Phase 4 study, has completed, sponsored by The University of Texas Health Science Center, Houston.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 1,561 participants
- Enrollment target
Study Summary
This is a comparative effectiveness study of current pain management strategies in acutely injured trauma patients. Two different multi-modal, opioid minimizing analgesic strategies will be compared \[original multimodal pain regimen (MMPR) compared to multi-modal analgesic strategies for trauma (MAST) MMPR\].
Interventions
- DRUG Ketorolac
- DRUG Naproxen
- DRUG Celebrex
- DRUG Acetaminophen IV/PO
- DRUG Acetaminophen PO
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,561 participants |
| Start Date | 2018-04-02 |
| Est. Completion | 2019-07-03 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03472469
The ClinicalTrials.gov registry entry for NCT03472469 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 1,561 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The University of Texas Health Science Center, Houston, which has 732 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Ketorolac is the first listed.
NCT03472469 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03472469 about?
NCT03472469 is a clinical study titled "MAST Trial: Multi-modal Analgesic Strategies in Trauma". This is a comparative effectiveness study of current pain management strategies in acutely injured trauma patients. Two different multi-modal, opioid minimizing analgesic strategies will be compared \[original multimodal pain regimen (MMPR) compared to multi-modal analgesic strategies for trauma (MA...
What is the current status of trial NCT03472469?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 1,561 participants. The study started on 2018-04-02. Estimated completion is 2019-07-03.
What interventions are being tested in trial NCT03472469?
The interventions under investigation include: Ketorolac (DRUG), Naproxen (DRUG), Celebrex (DRUG), Acetaminophen IV/PO (DRUG), Acetaminophen PO (DRUG).
Who is sponsoring clinical trial NCT03472469?
This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.